Back to search

A randomized, double‐blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors

Data up to Jan 2025

Published1998
Citations219
References29

Total Citations Per Year

Abstract

References (29)

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1992 • 613 citations

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

1993 • 482 citations

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

1994 • 352 citations

The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII

1981 • 303 citations

Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A

1990 • 261 citations

Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIII

1980 • 257 citations

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa

1994 • 256 citations

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A

1993 • 183 citations

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII

1993 • 164 citations

Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation

1995 • 162 citations

Thrombogenicity associated with factor IX complex concentrates.

1991 • 154 citations

The Use of Porcine Factor VIII Concentrate (Hyate:C) in the Treatment of Patients With Inhibitor Antibodies to Factor VIII

1989 • 151 citations

Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII

1983 • 125 citations

Major Surgery in Haemophilic Patients with Inhibitors Using Recombinant Factor VIla

1996 • 121 citations

Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.

1990 • 114 citations

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleedings in patients with haemophilia A with an inhibitor to Factor VIII

1982 • 90 citations

Recombinant Activated Factor VII in the Treatment of Bleeding Episodes in Patients With Inherited and Acquired Bleeding Disorders

1993 • 90 citations

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with Factor VIII deficiency and a factor VIII inhibitor

1988 • 81 citations

Recombinant Factor VIla (NovoSeven®) in the Treatment of Internal Bleeding in Patients with Factor VIM and IX Inhibitors

1996 • 75 citations

The incidence of factor VIII inhibitors in patients with severe hemophilia A

1995 • 71 citations

Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor

1989 • 63 citations

NovoSeven® (Recombinant Factor VIla) in Central Nervous System Bleeds

1996 • 62 citations

Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia a patients with inhibitors

1994 • 55 citations

Adverse Effects of Treatment with Porcine Factor VIII

1991 • 51 citations

Management of Hemophilia Patients with Inhibitors

1992 • 39 citations

Successful Hemostasis During a Major Orthopedic Operation by Using Recombinant Activated Factor VII in a Patient With Severe Hemophilia A and a Potent Inhibitor

1994 • 25 citations

Porcine factor VIII: preparation and use in treatment of inhibitor patients.

1984 • 24 citations

PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR‐IX‐DEFICIENT PATIENT WITH AN INHIBITOR

1991 • 20 citations

Activated recombinant factor VII in the treatment of retroperitoneal haemorrhage in a patient with factor VIII inhibitor.

1994 • 3 citations

Cited By (0)

Loading...